Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Acuitas Therapeutics, AskBio, Asklepios BioPharmaceutical, Bayer, Clinically validated, components, DNA, Dr. Thomas Madden, Friedemann Janus, gene editing, gene therapy, High potency ionizable lipid technology, Jost Reinhardt, lipid nanoparticle, LNP, LNP carriers, messenger RNA, molecular therapeutics, mRNA, RNA, vivo gene editing
(PRESS RELEASE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, and CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), have announced that their joint bid to … Read the full press release
Posted in Chemicals, Germany, Government, Healthcare, News, Pharma & Biotech, Technology
Tagged biotech site, Christian Hartel, CordenPharma, coronavirus pandemic, lipid nanoparticles, LNP, messenger ribonucleic acid, Michael Quirmbach, mRNA, pDNA, plasmid DNA, Susanne Leonhartsberger, vaccine, WACKER, Weinberg Campus
(COMMUNIQUÉ DE PRESSE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR : WCH), une multinationale chimique allemande, et CordenPharma , le service pharmaceutique mondial & plate-forme de fabrication de l’International Chemical Investors Group (ICIG), ont annoncé que leur offre … Read the full press release
Posted in Chemicals, Germany, Healthcare, Pharma & Biotech, Technology
Tagged acide ribonucléique messager, ADN plasmidique, ADNp, ARNm, campus de Weinberg, Christian Hartel, CordenPharma, LNP, Michael Quirmbach, nanoparticules lipidiques, pandémie de coronavirus, site de biotechnologie, Susanne Leonhartsberger, vaccin, WACKER
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
